N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-methoxypyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-6-methoxypyridine-3-carboxamide;2-amino-5-(3-fluoro-5-pyridin-3-ylphenyl)-3-methyl-5-phenylimidazol-4-one;4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide;6-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide

C129H157FN24O11 — CID 158794442

IUPACN-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-methoxypyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-6-methoxypyridine-3-carboxamide;2-amino-5-(3-fluoro-5-pyridin-3-ylphenyl)-3-methyl-5-phenylimidazol-4-one;4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide;6-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide
SMILESCCCN(CCC)C(=O)c1cc(CN2C(=O)C(c3ccccc3)(c3ccccc3)N=C2N)ccn1.CCCN(CCC)C(=O)c1cccc(CN2C(=O)C(c3ccccc3)(c3ccccc3)N=C2N)n1.CN1C(=O)C(c2ccccc2)(c2cc(F)cc(-c3cccnc3)c2)N=C1N.COc1cc(C(=O)N[C@@H]2CCC[C@H](C[C@@]3(CCC4CCCCC4)N=C(N)N(C)C3=O)C2)ccn1.COc1ccc(C(=O)N[C@@H]2CCC[C@H](C[C@@]3(CCC4CCCCC4)N=C(N)N(C)C3=O)C2)cn1
InChIInChI=1S/2C28H31N5O2.2C26H39N5O3.C21H17FN4O/c1-3-18-32(19-4-2)25(34)24-17-11-16-23(30-24)20-33-26(35)28(31-27(33)29,21-12-7-5-8-13-21)22-14-9-6-10-15-22;1-3-17-32(18-4-2)25(34)24-19-21(15-16-30-24)20-33-26(35)28(31-27(33)29,22-11-7-5-8-12-22)23-13-9-6-10-14-23;1-31-24(33)26(30-25(31)27,13-11-18-7-4-3-5-8-18)17-19-9-6-10-21(15-19)29-23(32)20-12-14-28-22(16-20)34-2;1-31-24(33)26(30-25(31)27,14-13-18-7-4-3-5-8-18)16-19-9-6-10-21(15-19)29-23(32)20-11-12-22(34-2)28-17-20;1-26-19(27)21(25-20(26)23,16-7-3-2-4-8-16)17-10-15(11-18(22)12-17)14-6-5-9-24-13-14/h5-17H,3-4,18-20H2,1-2H3,(H2,29,31);5-16,19H,3-4,17-18,20H2,1-2H3,(H2,29,31);12,14,16,18-19,21H,3-11,13,15,17H2,1-2H3,(H2,27,30)(H,29,32);11-12,17-19,21H,3-10,13-16H2,1-2H3,(H2,27,30)(H,29,32);2-13H,1H3,(H2,23,25)/t;;2*19-,21+,26+;/m..00./s1
InChIKeyISROMCBQOHNICM-JDZDPVOWSA-N
MW2238.83 g/mol
LogP18.12
Rot. Bonds37

About N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-methoxypyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-6-methoxypyridine-3-carboxamide;2-amino-5-(3-fluoro-5-pyridin-3-ylphenyl)-3-methyl-5-phenylimidazol-4-one;4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide;6-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide

N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-methoxypyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-6-methoxypyridine-3-carboxamide;2-amino-5-(3-fluoro-5-pyridin-3-ylphenyl)-3-methyl-5-phenylimidazol-4-one;4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide;6-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide (PubChem CID 158794442) has the molecular formula C129H157FN24O11 and a molecular weight of 2238.83 g/mol. Its IUPAC name is N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-methoxypyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-6-methoxypyridine-3-carboxamide;2-amino-5-(3-fluoro-5-pyridin-3-ylphenyl)-3-methyl-5-phenylimidazol-4-one;4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide;6-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide.

Molecular Properties

Compound NameN-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-methoxypyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-6-methoxypyridine-3-carboxamide;2-amino-5-(3-fluoro-5-pyridin-3-ylphenyl)-3-methyl-5-phenylimidazol-4-one;4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide;6-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide
PubChem CID158794442
Molecular FormulaC129H157FN24O11
Molecular Weight2238.83 g/mol
Exact Mass2237.24
IUPAC NameN-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-methoxypyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-6-methoxypyridine-3-carboxamide;2-amino-5-(3-fluoro-5-pyridin-3-ylphenyl)-3-methyl-5-phenylimidazol-4-one;4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide;6-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide
SMILESCCCN(CCC)C(=O)c1cc(CN2C(=O)C(c3ccccc3)(c3ccccc3)N=C2N)ccn1.CCCN(CCC)C(=O)c1cccc(CN2C(=O)C(c3ccccc3)(c3ccccc3)N=C2N)n1.CN1C(=O)C(c2ccccc2)(c2cc(F)cc(-c3cccnc3)c2)N=C1N.COc1cc(C(=O)N[C@@H]2CCC[C@H](C[C@@]3(CCC4CCCCC4)N=C(N)N(C)C3=O)C2)ccn1.COc1ccc(C(=O)N[C@@H]2CCC[C@H](C[C@@]3(CCC4CCCCC4)N=C(N)N(C)C3=O)C2)cn1
InChIInChI=1S/2C28H31N5O2.2C26H39N5O3.C21H17FN4O/c1-3-18-32(19-4-2)25(34)24-17-11-16-23(30-24)20-33-26(35)28(31-27(33)29,21-12-7-5-8-13-21)22-14-9-6-10-15-22;1-3-17-32(18-4-2)25(34)24-19-21(15-16-30-24)20-33-26(35)28(31-27(33)29,22-11-7-5-8-12-22)23-13-9-6-10-14-23;1-31-24(33)26(30-25(31)27,13-11-18-7-4-3-5-8-18)17-19-9-6-10-21(15-19)29-23(32)20-12-14-28-22(16-20)34-2;1-31-24(33)26(30-25(31)27,14-13-18-7-4-3-5-8-18)16-19-9-6-10-21(15-19)29-23(32)20-11-12-22(34-2)28-17-20;1-26-19(27)21(25-20(26)23,16-7-3-2-4-8-16)17-10-15(11-18(22)12-17)14-6-5-9-24-13-14/h5-17H,3-4,18-20H2,1-2H3,(H2,29,31);5-16,19H,3-4,17-18,20H2,1-2H3,(H2,29,31);12,14,16,18-19,21H,3-11,13,15,17H2,1-2H3,(H2,27,30)(H,29,32);11-12,17-19,21H,3-10,13-16H2,1-2H3,(H2,27,30)(H,29,32);2-13H,1H3,(H2,23,25)/t;;2*19-,21+,26+;/m..00./s1
InChIKeyISROMCBQOHNICM-JDZDPVOWSA-N
XLogP18.12
TPSA475.18 Ų
H-Bond Donors7
H-Bond Acceptors26
Rotatable Bonds37
Heavy Atoms165
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002238.83
LogP ≤ 518.12
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1026

Analyze N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-methoxypyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-6-methoxypyridine-3-carboxamide;2-amino-5-(3-fluoro-5-pyridin-3-ylphenyl)-3-methyl-5-phenylimidazol-4-one;4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide;6-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-methoxypyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-6-methoxypyridine-3-carboxamide;2-amino-5-(3-fluoro-5-pyridin-3-ylphenyl)-3-methyl-5-phenylimidazol-4-one;4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide;6-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide?
The IUPAC name of N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-methoxypyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-6-methoxypyridine-3-carboxamide;2-amino-5-(3-fluoro-5-pyridin-3-ylphenyl)-3-methyl-5-phenylimidazol-4-one;4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide;6-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide (CID 158794442) is N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-methoxypyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-6-methoxypyridine-3-carboxamide;2-amino-5-(3-fluoro-5-pyridin-3-ylphenyl)-3-methyl-5-phenylimidazol-4-one;4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide;6-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide.
What is the SMILES notation for N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-methoxypyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-6-methoxypyridine-3-carboxamide;2-amino-5-(3-fluoro-5-pyridin-3-ylphenyl)-3-methyl-5-phenylimidazol-4-one;4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide;6-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide?
The canonical SMILES for N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-methoxypyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-6-methoxypyridine-3-carboxamide;2-amino-5-(3-fluoro-5-pyridin-3-ylphenyl)-3-methyl-5-phenylimidazol-4-one;4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide;6-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide is CCCN(CCC)C(=O)c1cc(CN2C(=O)C(c3ccccc3)(c3ccccc3)N=C2N)ccn1.CCCN(CCC)C(=O)c1cccc(CN2C(=O)C(c3ccccc3)(c3ccccc3)N=C2N)n1.CN1C(=O)C(c2ccccc2)(c2cc(F)cc(-c3cccnc3)c2)N=C1N.COc1cc(C(=O)N[C@@H]2CCC[C@H](C[C@@]3(CCC4CCCCC4)N=C(N)N(C)C3=O)C2)ccn1.COc1ccc(C(=O)N[C@@H]2CCC[C@H](C[C@@]3(CCC4CCCCC4)N=C(N)N(C)C3=O)C2)cn1.
What is the InChIKey of N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-methoxypyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-6-methoxypyridine-3-carboxamide;2-amino-5-(3-fluoro-5-pyridin-3-ylphenyl)-3-methyl-5-phenylimidazol-4-one;4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide;6-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide?
The InChIKey is ISROMCBQOHNICM-JDZDPVOWSA-N. The full InChI is InChI=1S/2C28H31N5O2.2C26H39N5O3.C21H17FN4O/c1-3-18-32(19-4-2)25(34)24-17-11-16-23(30-24)20-33-26(35)28(31-27(33)29,21-12-7-5-8-13-21)22-14-9-6-10-15-22;1-3-17-32(18-4-2)25(34)24-19-21(15-16-30-24)20-33-26(35)28(31-27(33)29,22-11-7-5-8-12-22)23-13-9-6-10-14-23;1-31-24(33)26(30-25(31)27,13-11-18-7-4-3-5-8-18)17-19-9-6-10-21(15-19)29-23(32)20-12-14-28-22(16-20)34-2;1-31-24(33)26(30-25(31)27,14-13-18-7-4-3-5-8-18)16-19-9-6-10-21(15-19)29-23(32)20-11-12-22(34-2)28-17-20;1-26-19(27)21(25-20(26)23,16-7-3-2-4-8-16)17-10-15(11-18(22)12-17)14-6-5-9-24-13-14/h5-17H,3-4,18-20H2,1-2H3,(H2,29,31);5-16,19H,3-4,17-18,20H2,1-2H3,(H2,29,31);12,14,16,18-19,21H,3-11,13,15,17H2,1-2H3,(H2,27,30)(H,29,32);11-12,17-19,21H,3-10,13-16H2,1-2H3,(H2,27,30)(H,29,32);2-13H,1H3,(H2,23,25)/t;;2*19-,21+,26+;/m..00./s1.
What are the key properties of N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-methoxypyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-6-methoxypyridine-3-carboxamide;2-amino-5-(3-fluoro-5-pyridin-3-ylphenyl)-3-methyl-5-phenylimidazol-4-one;4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide;6-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide?
N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-methoxypyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-6-methoxypyridine-3-carboxamide;2-amino-5-(3-fluoro-5-pyridin-3-ylphenyl)-3-methyl-5-phenylimidazol-4-one;4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide;6-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide has a molecular weight of 2238.83 g/mol, XLogP of 18.12, 37 rotatable bonds, 7 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-2-methoxypyridine-4-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-6-methoxypyridine-3-carboxamide;2-amino-5-(3-fluoro-5-pyridin-3-ylphenyl)-3-methyl-5-phenylimidazol-4-one;4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide;6-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-2-carboxamide is sourced from PubChem (CID 158794442), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).